The price cuts are expected to reduce the cost of several anti-cancer medicines, making treatment more affordable for patients.
Anti-cancer drugs get cheaper by up to 96%

Revised prices for 1,364 anti-cancer drug formulations take effect, capping trade margins at 30%, saving patients Rs 3,540.38 crore annually…